Age, alcohol consumption, BMI, family history of colorectal cancer, history Distribution of WHS, of polyps, by Lin, 2004 Prospective 202/ Self report physical exposure Incidence, 0.56 vs 0.07 COL01834 Cohort, 37 547 verified by FFQ 1.23 (0.77-1.91) activity, category. colorectal cancer servings/day USA Age: 45- years, 8.7 years medical record postmenopausal Conversion from W hormone use, servings/day to randomized g/day treatment assignment, smoking habits, energy intake 102/ Incidence, Dutch 537 controls colorectal vs 0-1 0.70 (0.40-1.30) ≥4 prospective 8.5 cancer, times/month Monitoring Tiemersma, 54/ vs 0-1 Project on ≥4 Men 1.20 (0.60-2.40) 2002 Population 292 controls times/month Cardiovascular FFQ COL00563 registry Disease Risk 48/ vs 0-1 Netherlands ≥4 Women 0.50 (0.20-1.00) Factors, 145 controls times/month Nested Case Nat1 slow vs 0-1 Control, ≥4 0.60 (0.30-1.20) phenotype times/week
Lin, 2004 COL01834 USA WHS, Prospective Cohort, Age: 45- years, W 202/ 37 547 8.7 years Self report verified by medical record FFQ Incidence, colorectal cancer 0.56 vs 0.07 servings/day 1.23 (0.77-1.91) Age, alcohol consumption, BMI, family history of colorectal cancer, history of polyps, physical activity, postmenopausal hormone use, randomized treatment assignment, smoking habits, energy intake Distribution of by exposure category. Conversion from servings/day to g/day Tiemersma, 2002 COL00563 Netherlands Dutch prospective Monitoring Project on Cardiovascular Disease Risk Factors, Nested Case Control, 102/ 537 controls 8.5 Population registry FFQ Incidence, colorectal cancer, ≥4 vs 0-1 times/month 0.70 (0.40-1.30) 54/ 292 controls Men ≥4 vs 0-1 times/month 1.20 (0.60-2.40) 48/ 145 controls Women ≥4 vs 0-1 times/month 0.50 (0.20-1.00) Nat1 slow phenotype ≥4 vs 0-1 times/week 0.60 (0.30-1.20)
CUP_colorectal_SLR_2016_RO.docx